Neoplasms invade and metastasize degrading extracellular matrix (ECM), and therefore a large number of proteases involved in the invasion process have been extensively studied in order to understand tumour behaviour. Matrix metalloproteinases (MMPs) constitute a gene family of highly homologous enzymes capable of degrading ECM components, and play crucial roles in tumour progression (Liotta et al, 1991) . MMP-1 (interstitial collagenase) degrades types I, II and III collagens, and MMP-2 (72-kDa type IV collagenase) degrades gelatin, types IV, V, VII and X collagens. MMP-3 (stromelysin-1) with a broad substrate specificity, degrades proteoglycans, laminin, fibronectin, gelatin and types III, IV, V and IX collagens (Mauviel et al, 1993) . In skin cancer, the expression of MMP-1 and MMP-2 mRNAs has been revealed in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) (Gray et al, 1992; Pyke et al, 1992) . Recent studies have demonstrated that MMP-3 mRNA is expressed in BCC (Majmudar et al, 1994; Tsukifuji et al, 1997) .
In the present study, we investigated the expression of MMP-1, -2 and -3 in skin cancer, focusing on the early events occurring in invasive tumours. In situ hybridization can identify the cells responsible for the protein and detect the mRNA before its local accumulation. SCC and actinic keratosis (AK), a precancerous condition of SCC, were examined in this study, and the roles of MMPs during tumour progression were discussed.
MATERIALS AND METHODS

Tissue samples
Tissue specimens of skin tumours (15 SCCs, six AKs associated with SCC and 16 AKs) were obtained by surgical resection at Chiba University Hospital. The specimens were fixed in 10% buffered formalin immediately after the operation and embedded in paraffin. Four-micrometer tissue sections were mounted on aminoacyl silane-coated glass slides, dried overnight at 42°C and immediately used for in situ hybridization and immunohistochemical examination. The sections stained with haematoxylin and eosin were examined independently by two or more experienced pathologists and dermatologists for histological diagnosis. The patients with SCC were staged according to UICC TNM classification (Sobin et al, 1997) .
RNA probe preparation
RNA probe preparation for MMP-1 and MMP-3 has been described previously (Tsukifuji et al, 1997) . A template fragment for MMP-2 was obtained from human fibroblast MMP-2 cDNA (Collier et al, 1988) , using the restriction enzyme. Each fragment (the 1016-bp MMP-1 fragment extending from nucleotide 273 to 1289, the MMP-2 fragment from 1353 to 1747, and the 573-bp MMP-3 fragment from 828 to 1401) was subcloned into pGEM 7Z vector (Promega, Madison, WI, USA). Labelled probes were Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis synthesized by in vitro transcription with SP6 or T7 RNA polymerase using digoxigenin-labelled uridine triphosphate as substrate (Digoxigenin RNA labelling mixture, Boehringer Mannheim, Indianapolis, IN, USA).
In-situ hybridization
Details of the method have been reported previously (Tsukifuji et al, 1997) . Deparaffinized sections were treated with proteinase K (4 µg ml -1 ) at 37°C for 20 min, followed by rinsing in phosphatebuttered saline (PBS). Then the specimens were incubated with chondroitin ABC lyase, 0.02 units ml -1 (Seikagaku Kogyo, Tokyo, Japan), in buffer solution (0.1 M Tris-HC1 pH 8.0, 0.03 M sodium acetate, 0.05% bovine serum albumin) at 37°C for 30 min. After rinsing in PBS, the slides were refixed in 4% paraformaldehyde for 20 min, and then dipped in 2 mg ml -1 glycine for 15 min and 0.2 N hydrochloric acid for 10 min. Immediately after this pretreatment, the sections were prehybridized in 50% formamide and 2 × standard saline citrate at room temperature for 1 h. They were then covered with the antisense or sense RNA probe in hybridization buffer (50% formamide, 10% dextran sulphate, 1 × Denhardt's solution, 200 µg ml -1 yeast tRNA, 600 mM sodium chloride, 1 mM EDTA, 0.25% sodium dodecyl sulphate (SDS), 10 mM Tris-HCl pH 7.6) and incubated at 50°C for 18 h in a humidified chamber. The RNA probes of MMP-1, MMP-2 and MMP-3 were used at concentrations of 400, 700 and 700 ng ml -1 respectively. After hybridization, the slides were washed under stringent conditions and treated with RNAase to remove the unhybridized probes. The sections were incubated with 1.5% blocking reagent and antidigoxigenin antibody conjugated with alkaline phosphatase, 1: 500 (Boehringer Mannheim, Indianapolis, IN, USA) for 1 h at room temperature. After rinsing, labelling was visualized by colour products of Fast Red (BioGenex, San Ramon, CA, USA). Counterstaining was done with methyl green.
The evaluation was based on the mean number of labelled cells per high power field (hpf). A minimum of 8 hpfs and up to 15 hpfs were counted using a ×10 eyepiece and a × 40 objective lens and scored as follows; +++ > 20 cells: ++, 2-20 cells per hpf; +, 0.2-2 cells per hpf; -, < 0.2 cells per hpf.
Statistical methods
The semi-quantitative scores of in situ hybridization were evaluated using Kruskal-Wallis test or Pearson's correlation coefficient, and P < 0.05 was considered significant.
RESULTS
The results of semi-quantitative evaluation of in situ hybridization are summarized in Table 1 .
The expression of MMP-1, -2 and -3 mRNAs in SCC
The expression of MMP-1 mRNA was detected in all SCC samples. Distinct signals for MMP-1 mRNA were observed in tumour cells and spindle-shaped cells of the stroma ( Figure 1A , B). The tumour cells expressing MMP-1 mRNA were mainly located at the invasive area of the neoplasm. Fibroblast-like cells with the hybridization signals were observed mostly around the tumour nests. Generally, MMP-1 mRNA appeared to be more abundant in stromal cells than in tumour cells. Superficially invasive tumours in the early stage already demonstrated moderate signals for MMP-1, and those of deeply invasive ones were remarkably pronounced ( Table 1) .
The expression of MMP-3 mRNA was detected in 11 of the 15 SCCs. Fibroblast-like cells among the tumour nests and a few neoplastic cells were responsible for the hybridization signals for MMP-3 (Figure 1 C, D) .
The expression of MMP-2 mRNA was detected to various degrees in fibroblast-like cells of the stroma in all cases, but was not detected in tumour cells (Table 1) . The hybridization signals for MMP-2 were generally weak and scattered throughout the stroma ( Figure 1E, F) .
The expression of each MMP tended to increase according to the tumour progression but the differences were not significant (P > 0.1) in the tumour stages (I, II and III). The signals for MMP-3 were localized at limited areas, where abundant MMP-1 mRNA was usually observed (Figure 2A, B) . MMP-3-positive cells correlated with MMP-1-positive ones (P = 0.03) although the former were not as many as the latter (Table 1) . On the other hand, the expression of MMP-2 did not appear to have any relationship with those of MMP-1 (P = 0.20) and MMP-3 (P = 0.69) (Figure 1 G-I) .
Normal skin demonstrated no distinct signals for the MMP mRNAs examined. For a control study, the signals in serial sections treated with sense probes or RNAase were always compared at the same time. Hybridization with the sense probes showed no specific activity ( Figure 1B, D, F) and RNAase treatment before hybridization removed positive reactions to antisense probes.
The expression of MMP-1 mRNA in AK
MMP-1 mRNA was detected in four of the 16 AK specimens. The signals for MMP-1 were found at a minority of basal keratinocytes showing atypical nuclei and disorderly arrangement. Stromal cells in a dense inflammatory infiltrate were also positive for the MMP-1 probe (Figure 2A, B) . In another case, MMP-1 mRNA was expressed by the basal and suprabasal keratinocytes in the epidermis proliferating into the dermis (Figure 2C, D) . No distinct signals for MMP-2 and MMP-3 mRNAs were detected in these areas. Secondary changes such as erosion or ulceration were not observed near the positive signals. In AKs the signals for MMP-1 were detected in the anaplastic keratinocytes of hypertrophic epidermis with a dense inflammatory infiltrate in the dermis. The lesions of carcinoma in-situ found adjacent to invasive SCCs were also examined for MMP expression. All such cases examined in the study were found at sun-exposed sites in the elderly and considered to be AK. In four of six AKs accompanied by SCC, expression of MMP-1 mRNA was observed in the keratinocytes and stromal cells. Immunohistochemical staining for MMPs in AK was so weak that the localization of each MMP was not determined.
DISCUSSION
The most interesting finding in the present study is that MMP-1 mRNA was expressed in AK as well as invasive tumours. In several specimens of AKs and most of AKs associated with SCC, the distinct signals for MMP-1 mRNA were observed in the keratinocytes proliferating downwards. Since there was no erosion or ulceration in the vicinity of MMP-1-positive cells in the AK specimens, MMP-1 mRNA was not induced by acute phase reactions of the wound healing process (Inoue et al, 1995) . It has been reported that the activity of MMP-1 is required for keratinocyte migration on a type I collagen matrix (Pilcher et al, 1997) . It is possible that atypical keratinocytes expressing MMP-1 in AK could be involved in cell migration associated with the tumour progression.
The expression of MMP-1 mRNA was observed extensively in tumour and stromal cells of SCC, consistent with the previous report (Gray et al, 1992) . In basal cell carcinoma (BCC), which is rarely metastatic, MMP-1 mRNA was expressed in stromal cells and detected in relatively large tumours of nodulo-ulcerative type, but not in small tumours of superficial type (Tsukifuji et al, 1997) . On the contrary, MMP-1 was produced by tumour and stromal cells from the early stage of SCC and carcinoma in situ. These different patterns of MMP-1 expression might explain the differences in invasive and metastatic behaviour between SCC and BCC. Although it was suggested that MMP-3 could be significantly involved in the progression of SCC (Matrisian et al, 1991) , the expression of MMP-3 mRNA was difficult to detect in SCC by in situ hybridization (Muller et al, 1993) . Our study distinctly indicated that MMP-3 mRNA was expressed in SCC specimens which revealed MMP-1 mRNA at high levels. Its localization pattern suggests that its expression may be linked, to some degree, with that of MMP-1. Since MMP-3 mRNA was not detected in AK, MMP-3 seemed to be induced subsequently to MMP-1 during tumour invasion. MMP-1 and MMP-3 promoters contain a 12-Otetradecanoyl-phorbol-13 acetate (TPA)-responsive element that binds the transcription factor AP-1 (Angel et al, 1987) , and the two enzymes may be regulated by similar activating mechanisms.
The expression of MMP-2 mRNA did not correlate well with the SCC stages. MMP-2 mRNA was expressed throughout the stroma around the tumour mass, and this did not suggest a close interaction between tumour and stromal cells. However, our immunohistochemical examination demonstrated that MMP-2 protein appeared to be concentrated at the interface between the tumour mass and stroma (data not shown). As MMP-2 is supposed to be activated at cell surface , the localization of MMP-2 protein is an interesting issue in the regulation of MMPs.
As for the degradation of type IV collagen, we also searched MMP-9 gene expression, but it was undetectable in tumour cells or stromal cells. In SCC, MMP-9 mRNA seems to be expressed at low levels in small populations of tumour cells (Juarez et al, 1993) , and possibly stromal cells (Ståhle-Bäckdahl et al, 1993) . High levels of MMP-9 gene expression have been reported in ovarian tumours (Naylor et al, 1994 ), brain tumours (Nakagawa et al, 1994) and pancreatic tumours, while MMP-1 and MMP-3 were not detected in pancreatic tumours (Gress et al, 1995) . In breast carcinoma tissue, MMP-1 was especially abundant in scirrhous carcinoma, containing great amounts of interstitial collagen, compared to papillotubular and solid-tubular carcinoma by immunohistochemical examination (Iwata et al, 1996) . These reports suggest that the diversity of MMP gene expression in neoplasms may be related to the components of tumour-associated stroma as well as the origin and invasive behaviour of tumour cells.
Since MMP-3 can activate MMP-1 (Suzuki et al, 1990) , its production would enhance tumour invasion into the connective tissue containing abundant interstitial collagen. It was recently reported that skin tumours arising in mice deficient of c-fos, a member of the AP-1 family, failed to undergo malignant conversion, and neither MMP-1 nor MMP-3 was induced (Saez et al, 1995) . It is interesting and worthy of further investigation to try to determine how malignant tumour transformation is related to ECM-degrading capacity, including the expression of MMP-1 and MMP-3 in skin tumours.
Taken together, our study indicated that MMP-1, -2 and -3 showed different localization patterns in SCC. Abundant MMP-1 mRNA was detected in SCC, and moreover, it was expressed frequently in AK associated with SCC and sometimes in AK. Its expression in AK might be one of the markers for more advanced dysplastic states, progressing to SCC.
